US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Artrya Ltd (AYA) 銘柄情報

Artrya Ltd (AYA)

4.71

0.21

( 4.67% )

更新日時： 14:31:20

Artrya Ltd (AYA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

4.71

( 4.67% )

買値

4.69

売値

4.71

出来高

251,870

4.52 日の範囲 4.77

0.605 52 週間の範囲 5.24

時価総額

前日終値

4.50

始値

4.65

時刻

最終取引時間

14:31:20

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 485,406

発行済株式数

159,799,493

配当利回り

PER

-27.8

1 株当たり利益 (EPS)

-0.17

歳入

29k

純利益

-19.71M

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to ... Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

www.artrya.com

本社

West Perth, Australia

設立

2026

Artrya Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker AYA. The last closing price for Artrya was AUD4.50. Over the last year, Artrya shares have traded in a share price range of AUD 0.605 to AUD 5.24.

Artrya currently has 159,799,493 shares in issue. The market capitalisation of Artrya is AUD752.66 million. Artrya has a price to earnings ratio (PE ratio) of -27.80.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.1	2.16919739696	4.61	4.93	4.45	419000	4.66459617	DE
4	-0.41	-8.0078125	5.12	5.15	4.37	505699	4.72122951	DE
12	2.11	81.1538461538	2.6	5.15	2.55	457374	4.22903566	DE
26	0.76	19.2405063291	3.95	5.24	2.55	502636	3.98568657	DE
52	3.995	558.741258741	0.715	5.24	0.605	615803	3.12367862	DE
156	4.495	2090.69767442	0.215	5.24	0.16	287802	2.52183144	DE
260	3.26	224.827586207	1.45	5.24	0.16	216250	2.33142458	DE

AYA - Frequently Asked Questions (FAQ)

What is the current Artrya Ltd share price?

The current share price of Artrya Ltd is AUD 4.71

How many Artrya Ltd shares are in issue?

Artrya Ltd has 159,799,493 shares in issue

What is the market cap of Artrya Ltd?

The market capitalisation of Artrya Ltd is AUD 752.66M

What is the 1 year trading range for Artrya Ltd share price?

Artrya Ltd has traded in the range of AUD 0.605 to AUD 5.24 during the past year

What is the PE ratio of Artrya Ltd?

The price to earnings ratio of Artrya Ltd is -27.8

What is the cash to sales ratio of Artrya Ltd?

The cash to sales ratio of Artrya Ltd is 26.39k

What is the registered address of Artrya Ltd?

The registered address for Artrya Ltd is 1257 Hay Street, West Perth, Western Australia, 6005

What is the Artrya Ltd website address?

The website address for Artrya Ltd is www.artrya.com

Which industry sector does Artrya Ltd operate in?

Artrya Ltd operates in the Healthcare Providers & Services sector

Wolf-man jack

Wolf-man jack 6分前

WQLF SAYS ABSOLUTELY YES. Your Move WE understand YQU Understand, Have Mercy WQLF ahoooooo

Does CV SCIENCES have representatives that service retail store customers?

Yes, CV Sciences has dedicated representatives and strategic partners in the natural product channel th

US Market News

US Market News 7分前

QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and BiopharmaJune 15, 2026 1:30 AM
Business Wire Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity

Just give me $1.50

Just give me $1.50 8分前

That would require a CEO with at least a 5th grade education, of which The Rat never made it that far.

5th Grade Education:

✅️ Buy Mikah Adderall ownership
✅️ Exercise UN-deserved warrants
✅️ Reverse split and u

Just give me $1.50

Just give me $1.50 10分前

Huh?

We haven't been on the OTC since 2019.

Nasrat, 2017: "We WILL be on the Nasdaq within a couple of years and we WILL be in dollarland around that time within couple of years."

This price action is ridiculous lol otc

Porch Honkey

Porch Honkey 11分前

Corporate Actions

I must have been sleeping when this happened, lol.
Action Type Effective Date Symbol Description
Market Change 06/04/2026 ECOX Market change from Pink Limited to OTCID

G-star 15分前

Amazing. A penny stock getting more Sunday message-board reads than SpaceX is apparently the new benchmark for industrial disruption.

By that logic, a viral cat video is more valuable than NASA.
But congratulations on the breakout board victory. Truly the financial equivalent o

Vexari

Vexari 28分前

Hamlin is on a mission

Awesome to watch

RIP_GOP

RIP_GOP 32分前

Hopefully theres a mention of Dendritic Cell Vaccines. 😎👍🏽

BoWing

BoWing 34分前

US Market News

US Market News 37分前

ACI Worldwide and EPI to Power Instant Payments in EuropeJune 15, 2026 1:00 AM
Business Wire Strategic collaboration enables merchants and financial intermediaries across Europe to offer Wero as a new payment method to consumers and businesses.

Vexari

Vexari 38分前

Pick a wreck

As the tracks move on
My picks for next week: 97, 97, 97, 97 lol

mmayr

SpaceX IPO Mania Just Created A Huge Market Problem

https://youtu.be/B6C0n175xag?is=6Oz5oHJW4t4KLYWZ

AngeloFoca

AngeloFoca 60分前

When a complex cell therapy takes 2.5 to 3 years and remains fully active under review, history shows it is usually because both the company and the MHRA are actively grinding through the massive technical specifications required to structure a viable commercial rollout. MHRA: "Listen Linda... Once

pinhigh

pinhigh 1時間前

Have you given any thought to what you'll do with all your spare time should Biel's PPS rise considerably? It could reach a point where bashing the company and it's supporters becomes embarrassing. Go Biel!

4retire

4retire 1時間前

Yes, on the ring mat. Looks like they were one of the sponsors of this event

kayak_wench

kayak_wench 1時間前

OMG, the PR from Elite reported "IQVIA reported branded product sales for the twelve months ending March 2026 of $26 billion".
Your not going to believe the gold standard of pharma sales nor the PR from Elite?

This is from the IQVIA website
"Measures dollar and unit sale

Hey_Its_That_Guy

Hey_Its_That_Guy 1時間前

I don't know what about the alien wars (the little green men kind of alien), or Cuba, or the UFC match.

somberfox

somberfox 1時間前

you're upsetting frank with that talk, he's saying tuesday is permit and news.

JohnnyRotton

JohnnyRotton 1時間前

Was looking at companies with same revenue and some are over 200 dollars. If this becomes profitable could be that high. This is easily a 20 dollar stock IMHO. The shorts only have a little time.

price_and_volume

price_and_volume 1時間前

Correct - nobody cares about the "company."
...there is a huge difference between watching a stock and watching a company. There may be more to comment on in your tl,dr post but I admit i stopped reading after the first sentence when I realized you don't get it.

Whatevs, GLTA!

price_and_volume

price_and_volume 1時間前

I'd love one thx.
Grilled cheese anyone?

boston127

boston127 1時間前

I'm buying more in 9 hours.

As much as I can afford. Something very good is happening here.

Moose412

Moose412 1時間前

I'm looking for more homework. This time of the cycle excites me greatly, when TOS switches to the Sept contract, and both google and (!!!) etrade (!!!) won't switch until Thursday, I believe.

Makes for a lot of wonky numbers out of calculators. I'm interested in clarifying this macr

Amundi MSCI Europe ESG S...

Bond 3625% until Februar...

Personal Assets

Sphinx Resources

Lithium One Metals

Nuveen Georgia Quality M...

Anchorage Digital Share ...

International bond 1.467...

Mission Bancorp (ID)

MBH Mortgage Bank

Xtrackers IE Public

Aethero Share Cls Lvl Pr...

Incomeshares Microsoft M...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。